Skip to main content

Advertisement

SpringerLink
Log in

Chronic lung allograft dysfunction

  • Lung Transplant (M Zamora, Section Editor)
  • Published:
Current Respiratory Care Reports Aims and scope Submit manuscript

Abstract

The recognition that chronic graft dysfunction after lung transplantation is a heterogeneous phenomenon has led to the introduction of a new term: chronic lung allograft dysfunction (CLAD). An International Society for Heart and Lung Transplantation working group will determine a definition of CLAD in 2014. It is thought that CLAD should not totally replace bronchiolitis obliterans syndrome (BOS), the conventional phenotype of chronic graft dysfunction, but that it should be a more comprehensive category that includes BOS as a purely obstructive disorder. Another phenotype to be included is restrictive allograft syndrome, a restrictive form of graft dysfunction that is distinct from BOS. Neutrophilic reversible allograft dysfunction may be included in CLAD as well. Further discussion is required before including other conditions associated with impaired pulmonary function after transplantation. Recent progress in the management of patients with CLAD includes the development of a series of diagnostic tests and recognition of the benefits of a trial of low-dose azithromycin. Further refinement of our understanding of the pathophysiology of CLAD and clinical care pathways is necessary.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Sato M. Chronic Lung Allograft Dysfunction after Lung Transplantation: the Moving Target. Gen Thorac Cardiovasc Surg. 2013;61(2):67–78. One of the comprehensive reviews dealing with CLAD, this paper proposes detailed clinical approaches for suspected cases of CLAD. The review also ventures into putative mechanisms of CLAD in an effort to explain the involvement of different anatomical compartments in different forms of CLAD.

    Article  PubMed  Google Scholar 

  2. Kunsebeck HW, Kugler C, Fischer S, Simon AR, Gottlieb J, Welte T, et al. Quality of life and bronchiolitis obliterans syndrome in patients after lung transplantation. Prog Transplant. 2007;17(2):136–41.

    PubMed  Google Scholar 

  3. Christie JD, Edwards LB, Kucheryavaya AY, Benden C, Dipchand AI, Dobbels F, et al. The Registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report-2012. J Heart Lung Transplant. 2012;31(10):1073–86.

    Article  PubMed  Google Scholar 

  4. Verleden GM, Raghu G, Meyer KC, Glanville AR, Corris P. A new classification system for chronic lung allograft dysfunction. J Heart Lung Transplant. 2014;33(2):127–33. This recent paper proposes a new classification of CLAD. Notably, this is not an official proposal from the CLAD working group of ISHLT.

    Article  PubMed  Google Scholar 

  5. Cooper JD, Billingham M, Egan T, Hertz MI, Higenbottam T, Lynch J, et al. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 1993;12:713–6.

    CAS  PubMed  Google Scholar 

  6. Snell GI, Levvey B, Westall GP. Non-bronchiolitis obliterans syndrome forms of chronic lung allograft dysfunction. In: Meyer KC, Glanville AR, editors. Bronchiolitis Obliterans Syndrome in Lung Transplantation. New York: Springer; 2013. p. 47–58. This is a book chapter dealing with the new framework of CLAD in a comprehensive manner.

    Chapter  Google Scholar 

  7. Sato M, Waddell TK, Wagnetz U, Roberts HC, Hwang DM, Haroon A, et al. Restrictive Allograft Syndrome (RAS): a novel form of chronic allograft dysfunction after lung transplantation. J Heart Lung Transplant. 2011;30(7):735–42. This is the first report on RAS from the Toronto group. The paper describes, for the first time, physiological, radiological, and pathological characteristics of RAS as well as prevalence and survival of RAS.

    Article  PubMed  Google Scholar 

  8. Vanaudenaerde BM, Meyts I, Vos R, Geudens N, De Wever W, Verbeken EK, et al. A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy. Eur Respir J. 2008;32(4):832–43.

    Article  CAS  PubMed  Google Scholar 

  9. Stewart S, Fishbein MC, Snell GI, Berry GJ, Boehler A, Burke MM, et al. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant. 2007;26:1229–42.

    Article  PubMed  Google Scholar 

  10. Yousem SA, Burke CM, Billingham ME. Pathologic pulmonary alterations in long-term human heart-lung transplantation. Hum Pathol. 1985;16(9):911–23.

    Article  CAS  PubMed  Google Scholar 

  11. Ryu JH, Myers JL, Swensen SJ. Bronchiolar disorders. Am J Respir Crit Care Med. 2003;168:1277–92.

    Article  PubMed  Google Scholar 

  12. Estenne M, Maurer JR, Boehler A, Egan JJ, Frost A, Hertz M, et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant. 2002;21:297–310.

    Article  PubMed  Google Scholar 

  13. Lama VN, Murray S, Lonigro RJ, Toews GB, Chang A, Lau C, et al. Course of FEV(1) after onset of bronchiolitis obliterans syndrome in lung transplant recipients. Am J Respir Crit Care Med. 2007;175:1192–8.

    Article  PubMed Central  PubMed  Google Scholar 

  14. Finlen Copeland CA, Snyder LD, Zaas DW, Turbyfill WJ, Davis WA, Palmer SM. Survival after bronchiolitis obliterans syndrome among bilateral lung transplant recipients. Am J Respir Crit Care Med. 2010;182(6):784–9.

    Article  PubMed Central  PubMed  Google Scholar 

  15. Jackson CH, Sharples LD, McNeil K, Stewart S, Wallwork J. Acute and chronic onset of bronchiolitis obliterans syndrome (BOS): are they different entities? J Heart Lung Transplant. 2002;21:658–66.

    Article  PubMed  Google Scholar 

  16. Konen E, Gutierrez C, Chaparro C, Murray CP, Chung T, Crossin J, et al. Bronchiolitis obliterans syndrome in lung transplant recipients: can thin-section CT findings predict disease before its clinical appearance? Radiology. 2004;231:467–73.

    Article  PubMed  Google Scholar 

  17. Heng D, Sharples LD, McNeil K, Stewart S, Wreghitt T, Wallwork J. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors. J Heart Lung Transplant. 1998;17:1255–63.

    CAS  PubMed  Google Scholar 

  18. Husain AN, Siddiqui MT, Holmes EW, Chandrasekhar AJ, McCabe M, Radvany R, et al. Analysis of risk factors for the development of bronchiolitis obliterans syndrome. Am J Respir Crit Care Med. 1999;159:829–33.

    Article  CAS  PubMed  Google Scholar 

  19. Fiser SM, Tribble CG, Long SM, Kaza AK, Kern JA, Jones DR, et al. Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome. Ann Thorac Surg. 2002;73:1041–7. discussion 7–8.

    Article  PubMed  Google Scholar 

  20. Husain S, Singh N. Bronchiolitis obliterans and lung transplantation: evidence for an infectious etiology. Semin Respir Infect. 2002;17(4):310–4.

    Article  PubMed  Google Scholar 

  21. Palmer SM, Davis RD, Hadjiliadis D, Hertz MI, Howell DN, Ward FE, et al. Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome. Transplantation. 2002;74:799–804.

    Article  CAS  PubMed  Google Scholar 

  22. Chalermskulrat W, Neuringer IP, Schmitz JL, Catellier DJ, Gurka MJ, Randell SH, et al. Human leukocyte antigen mismatches predispose to the severity of bronchiolitis obliterans syndrome after lung transplantation. Chest. 2003;123:1825–31.

    Article  PubMed  Google Scholar 

  23. Hachem RR, Khalifah AP, Chakinala MM, Yusen RD, Aloush AA, Mohanakumar T, et al. The significance of a single episode of minimal acute rejection after lung transplantation. Transplantation. 2005;80:1406–13.

    Article  PubMed  Google Scholar 

  24. Botha P, Archer L, Anderson RL, Lordan J, Dark JH, Corris PA, et al. Pseudomonas aeruginosa colonization of the allograft after lung transplantation and the risk of bronchiolitis obliterans syndrome. Transplantation. 2008;85(5):771–4.

    Article  PubMed  Google Scholar 

  25. Glanville AR, Aboyoun CL, Havryk A, Plit M, Rainer S, Malouf MA. Severity of lymphocytic bronchiolitis predicts long-term outcome after lung transplantation. Am J Respir Crit Care Med. 2008;177(9):1033–40.

    Article  PubMed  Google Scholar 

  26. Zheng L, Walters EH, Ward C, Wang N, Orsida B, Whitford H, et al. Airway neutrophilia in stable and bronchiolitis obliterans syndrome patients following lung transplantation. Thorax. 2000;55:53–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  27. D'Ovidio F, Mura M, Tsang M, Waddell TK, Hutcheon MA, Singer LG, et al. Bile acid aspiration and the development of bronchiolitis obliterans after lung transplantation. J Thorac Cardiovasc Surg. 2005;129:1144–52.

    Article  PubMed  Google Scholar 

  28. Huang HJ, Yusen RD, Meyers BF, Walter MJ, Mohanakumar T, Patterson GA, et al. Late primary graft dysfunction after lung transplantation and bronchiolitis obliterans syndrome. Am J Transplant. 2008;8(11):2454–62.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  29. Yousem SA. Lymphocytic bronchitis/bronchiolitis in lung allograft recipients. Am J Surg Pathol. 1993;17:491–6.

    Article  CAS  PubMed  Google Scholar 

  30. Boehler A, Estenne M. Post-transplant bronchiolitis obliterans. Eur Respir J. 2003;22(6):1007–18.

    Article  CAS  PubMed  Google Scholar 

  31. Verleden SE, de Jong PA, Ruttens D, Vandermeulen E, van Raemdonck DE, Verschakelen J, et al. Functional and computed tomographic evolution and survival of restrictive allograft syndrome after lung transplantation. J Heart Lung Transplant. 2014;33(3):270–7.

    Article  PubMed  Google Scholar 

  32. Todd JL, Jain R, Pavlisko EN, Finlen Copeland CA, Reynolds JM, Snyder LD, et al. Impact of forced vital capacity loss on survival after the onset of chronic lung allograft dysfunction. Am J Respir Crit Care Med. 2014;189(2):159–66.

    PubMed  Google Scholar 

  33. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis. 1991;144(5):1202–18.

    Article  Google Scholar 

  34. Sato M, Hwang DM, Ohmori-Matsuda K, Chaparro C, Waddell TK, Singer LG, et al. Revisiting the pathologic finding of diffuse alveolar damage after lung transplantation. J Heart Lung Transplant. 2012;31(4):354–63.

    Article  PubMed  Google Scholar 

  35. Hirota T, Fujita M, Matsumoto T, Higuchi T, Shiraishi T, Minami M, et al. Pleuroparenchymal fibroelastosis as a manifestation of chronic lung rejection? Eur Respir J. 2013;41(1):243–5.

    Article  PubMed  Google Scholar 

  36. Ofek E, Sato M, Saito T, Wagnetz U, Roberts HC, Chaparro C, et al. Restrictive allograft syndrome post lung transplantation is characterized by pleuroparenchymal fibroelastosis. Mod Pathol. 2013;26(3):350–6. This paper demonstrates that pleuroparenchymal fibroelastosis, a histological characteristic of RAS at the fibrosis stage, is a characteristic also seen in the restrictive form of chronic graft-versus-host disease after hematopoietic stem cell transplantation.

    Article  CAS  PubMed  Google Scholar 

  37. Paraskeva M, McLean C, Ellis S, Bailey M, Williams T, Levvey B, et al. Acute fibrinoid organizing pneumonia after lung transplantation. Am J Respir Crit Care Med. 2013;187(12):1360–8.

    Article  PubMed  Google Scholar 

  38. Sato M, Hwang DM, Waddell TK, Singer LG, Keshavjee S. Progression pattern of restrictive allograft syndrome after lung transplantation. J Heart Lung Transplant. 2013;32(1):23–30.

    Article  PubMed  Google Scholar 

  39. Verleden GM, Vos R, Verleden SE, De Wever W, De Vleeschauwer SI, Willems-Widyastuti A, et al. Survival determinants in lung transplant patients with chronic allograft dysfunction. Transplantation. 2011;92(6):703–8. This is the second report of RAS clearly demonstrating the reproducibility of the Toronto data in reference [7].

    Article  PubMed  Google Scholar 

  40. Verleden SE, Ruttens D, Vandermeulen E, Vaneylen A, Dupont LJ, Van Raemdonck DE, et al. Bronchiolitis obliterans syndrome and restrictive allograft syndrome: do risk factors differ? Transplantation. 2013;95(9):1167–72.

    Article  PubMed  Google Scholar 

  41. Verleden SE, Ruttens D, Vandermeulen E, van Raemdonck DE, Vanaudenaerde BM, Verleden GM, et al. Elevated bronchoalveolar lavage eosinophilia correlates with poor outcome after lung transplantation. Transplantation. 2014;97(1):83–9. This report describing the strong association between RAS and airway eosinophilia comes close to identifying, for the first time, the underlying mechanism of RAS.

    Article  PubMed  Google Scholar 

  42. Yates B, Murphy DM, Forrest IA, Ward C, Rutherford RM, Fisher AJ, et al. Azithromycin reverses airflow obstruction in established bronchiolitis obliterans syndrome. Am J Respir Crit Care Med. 2005;172:772–5.

    Article  PubMed  Google Scholar 

  43. Zheng L, Whitford HM, Orsida B, Levvey BJ, Bailey M, Walters EH, et al. The dynamics and associations of airway neutrophilia post lung transplantation. Am J Transplant. 2006;6:599–608.

    Article  CAS  PubMed  Google Scholar 

  44. Verleden GM, Vanaudenaerde BM, Dupont LJ, Van Raemdonck DE. Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome. Am J Respir Crit Care Med. 2006;174:566–70.

    Article  CAS  PubMed  Google Scholar 

  45. Vos R, Vanaudenaerde BM, Verleden SE, De Vleeschauwer SI, Willems-Widyastuti A, Van Raemdonck DE, et al. Bronchoalveolar lavage neutrophilia in acute lung allograft rejection and lymphocytic bronchiolitis. J Heart Lung Transplant. 2010;29(11):1259–69.

    Article  PubMed  Google Scholar 

  46. Hachem RR, Yusen RD, Meyers BF, Aloush AA, Mohanakumar T, Patterson GA, et al. Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation. J Heart Lung Transplant. 2010;29(9):973–80.

    Article  PubMed Central  PubMed  Google Scholar 

  47. Burlingham WJ, Love RB, Jankowska-Gan E, Haynes LD, Xu Q, Bobadilla JL, et al. IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants. J Clin Invest. 2007;117:3498–506.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  48. Goers TA, Ramachandran S, Aloush A, Trulock E, Patterson GA, Mohanakumar T. De Novo Production of K-{alpha}1 Tubulin-Specific Antibodies: Role in Chronic Lung Allograft Rejection. J Immunol. 2008;180:4487–94.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  49. Billings JL, Hertz MI, Savik K, Wendt CH. Respiratory viruses and chronic rejection in lung transplant recipients. J Heart Lung Transplant. 2002;21:559–66.

    Article  PubMed  Google Scholar 

  50. Blondeau K, Mertens V, Vanaudenaerde BA, Verleden GM, Van Raemdonck DE, Sifrim D, et al. Gastro-oesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection. Eur Respir J. 2008;31(4):707–13.

    Article  CAS  PubMed  Google Scholar 

  51. Whitson BA, Prekker ME, Herrington CS, Whelan TP, Radosevich DM, Hertz MI, et al. Primary graft dysfunction and long-term pulmonary function after lung transplantation. J Heart Lung Transplant. 2007;26(10):1004–11.

    Article  PubMed  Google Scholar 

  52. Sato M, Keshavjee S. Bronchiolitis obliterans syndrome: alloimmune-dependent and -independent injury with aberrant tissue remodeling. Semin Thorac Cardiovasc Surg. 2008;20(2):173–82.

    Article  PubMed  Google Scholar 

  53. McNeil K, Glanville AR, Wahlers T, Knoop C, Speich R, Mamelok RD, et al. Comparison of mycophenolate mofetil and azathioprine for prevention of bronchiolitis obliterans syndrome in de novo lung transplant recipients. Transplantation. 2006;81:998–1003.

    Article  CAS  PubMed  Google Scholar 

  54. Iacono AT, Johnson BA, Grgurich WF, Youssef JG, Corcoran TE, Seiler DA, et al. A randomized trial of inhaled cyclosporine in lung-transplant recipients. N Engl J Med. 2006;354:141–50.

    Article  PubMed  Google Scholar 

  55. Cantu 3rd E, Appel 3rd JZ, Hartwig MG, Woreta H, Green C, Messier R, et al. Early fundoplication prevents chronic allograft dysfunction in patients with gastroesophageal reflux disease. Ann Thorac Surg. 2004;78(4):1142–51. discussion -51.

    Article  PubMed  Google Scholar 

  56. Vos R, Vanaudenaerde BM, Verleden SE, De Vleeschauwer SI, Willems-Widyastuti A, Van Raemdonck DE, et al. A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation. Eur Respir J. 2011;37(1):164–72.

    Article  CAS  PubMed  Google Scholar 

  57. Lama VN, Murray S, Mumford JA, Flaherty KR, Chang A, Toews GB, et al. Prognostic value of bronchiolitis obliterans syndrome stage 0-p in single-lung transplant recipients. Am J Respir Crit Care Med. 2005;172:379–83.

    Article  PubMed Central  PubMed  Google Scholar 

  58. Davis Jr RD, Lau CL, Eubanks S, Messier RH, Hadjiliadis D, Steele MP, et al. Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation. J Thorac Cardiovasc Surg. 2003;125:533–42.

    Article  PubMed  Google Scholar 

  59. Greer M, Dierich M, De Wall C, Suhling H, Rademacher J, Welte T, et al. Phenotyping established chronic lung allograft dysfunction predicts extracorporeal photopheresis response in lung transplant patients. Am J Transplant. 2013;13(4):911–8.

    Article  CAS  PubMed  Google Scholar 

  60. Warnecke G, Haverich A. Lung re-transplantation: review. Curr Opin Organ Transplant. 2012;17(5):485–9.

    Article  PubMed  Google Scholar 

  61. Sato M, Ohmori-Matsuda K, Saito T, Matsuda Y, Hwang DM, Waddell TK, et al. Time-dependent changes in the risk of death in pure bronchiolitis obliterans syndrome (BOS). J Heart Lung Transplant. 2013;32(5):484–91.

    Article  PubMed  Google Scholar 

  62. Stilley CS, Dew MA, Stukas AA, Switzer GE, Manzetti JD, Keenan RJ, et al. Psychological symptom levels and their correlates in lung and heart-lung transplant recipients. Psychosomatics. 1999;40(6):503–9.

    Article  CAS  PubMed  Google Scholar 

  63. Song MK, DeVito Dabbs A, Studer SM, Arnold RM. Palliative care referrals after lung transplantation in major transplant centers in the United States. Crit Care Med. 2009;37(4):1288–92.

    Article  PubMed  Google Scholar 

  64. Lanken PN, Terry PB, Delisser HM, Fahy BF, Hansen-Flaschen J, Heffner JE, et al. An official American Thoracic Society clinical policy statement: palliative care for patients with respiratory diseases and critical illnesses. Am J Respir Crit Care Med. 2008;177(8):912–27.

    Article  PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Masaaki Sato has declared that he has no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. Department of Thoracic Surgery, Kyoto University Hospital, 54-Kawara-chyo, Sakyo-ku, Kyoto, 606-8507, Japan

    Masaaki Sato

  2. Latner Thoracic Surgery Research Laboratories, University of Toronto, Toronto, ON, Canada

    Masaaki Sato

Authors
  1. Masaaki Sato
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Masaaki Sato.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sato, M. Chronic lung allograft dysfunction. Curr Respir Care Rep 3, 71–78 (2014). https://doi.org/10.1007/s13665-014-0079-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13665-014-0079-z

Keywords

Search

Navigation